Assessment of a Cosmetic Product Effect on the Host/Microorganism Relationship in Acneic Subjects

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

41 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-20

Study Completion Date

2022-01-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to understand the structural and functional modifications of the host, the microorganisms, and their interactions (host/microorganism relationship) before and after the RV3278A - ET0943 product application

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin

NCT04873089

Acne

COMPLETED

Efficacy of Cosmetic Product RV3278B-OS0386 on Skin Surface Ecosystem, in Teenagers with Mild to Moderate Facial Acne

NCT06659861

Acne

COMPLETED NA

Assess the Effects and the Tolerance of Cosmetic Product in the Follow-up Phase of Facial Acne for 1 Year

NCT04301063

Acne Vulgaris

COMPLETED

Assessment of Biological, Biometrological Parameters and Consumer Needs in Adult Subjects with Acne

NCT06841393

Acne Healthy

TERMINATED NA

A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne

NCT03450369

Acne Vulgaris

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acne

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RV3278A arm : Treated group

This group will receive the RV3278A - ET0943 product

RV3278A - ET0943 cosmetic product

Intervention Type OTHER

RV3278A - ET0943 study product is applied twice a day on the face during the whole study.

RV4632A arm : Control group

This group will receive the RV4632A - RY1845 product

RV4632A - RY1845 cosmetic product

Intervention Type OTHER

RV4632A - RY1845 study product must be applied only in case of sensation of skin discomfort

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RV3278A - ET0943 cosmetic product

RV3278A - ET0943 study product is applied twice a day on the face during the whole study.

Intervention Type OTHER

RV4632A - RY1845 cosmetic product

RV4632A - RY1845 study product must be applied only in case of sensation of skin discomfort

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Related to the population:

\- Subject aged between 12 to 25 years included
2. Related to diseases:

* Subject having acne lesions on the face, with GEA (Global Acne Evaluation) score on the face is assessed as 2 (mild) or as 3 (moderate), on a scale ranged from 0 (clear- no lesion) to 5 (very severe)
* Subject having at least 20 open-comedones of about 1 mm in diameter on the face and possibly extractable
* Subject having a predominance of non-inflammatory acne lesions

Exclusion Criteria

1. Related to diseases:

* Subject having comedones only on the nose wings
* Subject with any other dermatological disease than acne or skin characteristics (like scar, tatoo) on the face liable to interfere with the study according to the investigator's assessment
* Subject with an acute or chronic disease, or history of disease liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements
* Severe form of acne (Acne conglobata, Acne fulminans or nodulokystic acne) or acneiform induced rashes according to the investigator's assessment
* Clinical signs of a hormonal dysfunction or of a hyperandrogenism
* Solar erythema on the face due to excessive UV exposur
2. Related to the treatments/products:

* Any previous/concomitant treatment or product considered by the Investigator liable to interfere with the study data or incompatible with the study requirements or hazardous for the subject

Minimum Eligible Age

12 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No